General rule in biotech; buyout is 4x - 4.5x multiple of revenue. Say top end here which = 4.5 x 3.4 = NZ$15.3M.
This = 3.3c per share.
Sorry, but that's what I would expect if its bought out right now.
Printable View
General rule in biotech; buyout is 4x - 4.5x multiple of revenue. Say top end here which = 4.5 x 3.4 = NZ$15.3M.
This = 3.3c per share.
Sorry, but that's what I would expect if its bought out right now.
http://www.sharechat.co.nz/article/c...-in-focus.html
"Cash will become a concern in several months' time ... because these slow negotiations".
Note the way these analysts do not do any research whatsoever, relying almost entirely on the words of the companies they 'analyze'?
How the heck do they know that the negotiations are slow? Have they checked?
Given PEB's track record of misleading the market and quietly dropping follow ups when nothing happens, the negotiations may already be dead.
About 2 and a half years ago (either oct or nov 2015) I said I would give PEB 2 years to deliver something.
That something, mainly Kaiser Permanente & CMS, has not been delivered, despite my generosity in giving them another half year.
I am not sure what is going on, but I feel this should have been delivered.
PEB is the only share that is in the red (although has always been a low single digit percentage of the portfolio) and the only share on the dozen or two I have commented on sharetrader I seem to have been seriously out of step with.
It is unfortunate... I don't want to sell because it should be a success... maybe one day it will, but as far as my conclusions go, it has not been a success... the 'now or never' phase is passing, if not already passed, and every day that goes by is a step closer to the grave yard, joining the likes of WYN, CBL and PPL - previous bigly growth companies that just couldn't make it work (for various, and yes quite different, reasons)
I intend to remove myself from the share register in due course.
Sad?
Tragic that so many on this site chose to ignore the obvious (like ever increasing receivables) highlighted by posters as indicative of a company whose accounts and projections cannot be trusted.
What's even more tragic is that one poster here went so far as to dispute (implying he had confirmation from the company) that PEB was giving out free tests in its user programs.
This company to me will always be remembered for the statement by the then Chairman of 'several tens of thousands of tests' in late 2013 and his subsequent sale of shares, along with the CEO in 2014.
t_j said - I intend to remove myself from the share register in due course.
Sounds like shReholder suicide .....you going to sell or just ask the registry to remove your name.